Featured Research

from universities, journals, and other organizations

Gatekeeper signal controls skin inflammation

Date:
January 26, 2012
Source:
Cell Press
Summary:
A new study unravels key signals that regulate protective and sometimes pathological inflammation of the skin. The research identifies a "gatekeeper" that, when lost, can cause inflammatory skin disease in the absence of injury or infection. The findings may eventually lead to new treatment strategies for the more than 10 percent of people in the western world that suffer from inflammatory skin diseases.

A new study unravels key signals that regulate protective and sometimes pathological inflammation of the skin. The research, published online on January 26th in the journal Immunity by Cell Press, identifies a "gatekeeper" that, when lost, can cause inflammatory skin disease in the absence of injury or infection. The findings may eventually lead to new treatment strategies for the more than 10% of people in the western world that suffer from inflammatory skin diseases.

Although the skin typically remains in a "quiet" state, injury or invading pathogens cause skin cells to sound the alarm and mobilize an impressive immune response called inflammation. Inflammation of the skin is a powerful and appropriate response to infection or injury, but overzealous or unwarranted inflammation of the skin is harmful. Therefore, it is important to understand how skin cells regulate the function of immune cells.

"We knew that skin cells called keratinocytes direct the local immune response, yet the signaling networks in the skin that control the immune response were poorly defined," explains senior study author, Dr. Rama Khokha, from the Ontario Cancer Institute. "In our study we investigated whether an enzyme called ADAM17 is involved in crosstalk between the skin and the immune system. ADAM17 sheds proteins from the cell surface and has been implicated in immune cell function and development."

Aditya Murphy of the Khokha lab inactivated the gene for ADAM17 in the skin of adult mice and observed spontaneous production of inflammatory proteins by keratinocytes, culminating in skin inflammation and immune cell proliferation. Khokha and colleagues went on to show that ADAM17 controls Notch signaling in the adult epidermis (the outer layer of the skin). The Notch signaling pathway has been linked with the maintenance of normal skin and was recently implicated in preventing inflammatory skin disease. Importantly, reactivation of Notch rescued local skin inflammation and abnormal immune cell proliferation in the mice lacking the gene for ADAM17.

"Our study provides the first demonstration of the physiological requirement of ADAM17 in Notch signaling and demonstrates that loss of this gatekeeper triggers an immune response, even in the absence of injury or infection," concludes Dr. Khokha. "A better understanding of the mechanisms that regulate communication between immune and non-immune cells will be of significant value in the treatment of diseases affecting the skin and other barrier tissues."


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Aditya Murthy, Yang Washington Shao, Swami R. Narala, Sam D. Molyneux, Juan Carlos Zúñiga-Pflücker, Rama Khokha. Notch Activation by the Metalloproteinase ADAM17 Regulates Myeloproliferation and Atopic Barrier Immunity by Suppressing Epithelial Cytokine Synthesis. Immunity, 2012; 36 (1): 105 DOI: 10.1016/j.immuni.2012.01.005

Cite This Page:

Cell Press. "Gatekeeper signal controls skin inflammation." ScienceDaily. ScienceDaily, 26 January 2012. <www.sciencedaily.com/releases/2012/01/120126123659.htm>.
Cell Press. (2012, January 26). Gatekeeper signal controls skin inflammation. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/01/120126123659.htm
Cell Press. "Gatekeeper signal controls skin inflammation." ScienceDaily. www.sciencedaily.com/releases/2012/01/120126123659.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins